Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN. Gonzalez-Angulo AM, et al. Among authors: guray m. J Clin Oncol. 2009 Dec 1;27(34):5700-6. doi: 10.1200/JCO.2009.23.2025. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884543 Free PMC article.
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Albert JM, et al. Among authors: guray m. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1296-302. doi: 10.1016/j.ijrobp.2009.12.011. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2010. PMID: 20472353
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.
Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Albert JM, et al. Among authors: guray m. Cancer. 2011 Apr 15;117(8):1595-601. doi: 10.1002/cncr.25694. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472707 Free article.
In situ hybridization analysis of invasive breast carcinomas with immunohistochemically negative Her-2 status (a national multicenter study).
Tuzlali S, Yavuz E, Canda T, Güray M, Geçer MO, Süllü Y, Sezer C, Süren D, Sak SD, Calay Z, Ilvan S, Zorludemır S, Ergın M, Karavelı FS, Peşterelı E, Ozdener F, Ustündağ K. Tuzlali S, et al. Among authors: guray m. Turk Patoloji Derg. 2014;30(2):87-93. doi: 10.5146/tjpath.2014.01240. Turk Patoloji Derg. 2014. PMID: 24782296 Free article.
27 results